Andrew Hykes, President and CEO at Inari Medical, Inc. (NARI), sold 73,148 shares at $70.87 ($5.1M) on 2023-05-16, disclosed to the SEC on 2023-05-18.
Seasonal sale ($5.1M) by President and CEO — this insider has traded NARI in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.87 | 153 | $11K | 0.2% |
| 2 | $70.87 | 818 | $58K | 1.1% |
| 3 | $70.87 | 818 | $58K | 1.1% |
| 4 | $70.87 | 16,945 | $1.2M | 23.5% |
| 5 | $70.87 | 16,945 | $1.2M | 23.5% |
| 6 | $69.19 | 51 |
| $4K |
| 0.1% |
| 7 | $69.19 | 2,630 | $182K | 3.6% |
| 8 | $69.19 | 2,630 | $182K | 3.6% |
| 9 | $69.19 | 16,079 | $1.1M | 21.7% |
| 10 | $69.19 | 16,079 | $1.1M | 21.7% |
| Total | $70.01 avg | 73,148 | $5.1M | 100% |
| Filing → |
| NARI | SELL | 2024-10-31 | $150K | — | Filing → |
| NARI | SELL | 2024-08-22 | $150K | — | Filing → |
| NARI | SELL | 2024-07-24 | $166K | — | Filing → |